Steven Cohen Horizon Therapeutics Public LTD CO Transaction History

Point72 Asset Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $17.3 Million - $20.3 Million	175,000 New	175,000 $20.2 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $123 Million - $177 Million	2,094,400 New	2,094,400 $130 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $20 Million - $24.4 Million	-203,378 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $78.4 Million - $94.1 Million	-852,493 Reduced 80.74%	203,378 $22.3 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $91.1 Million - $101 Million	1,055,871 New	1,055,871 $98.9 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $29.7 Million - $37.4 Million	-443,270 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $24.5 Million - $35.4 Million	443,270 New	443,270 $34.4 Million
Q3 2019 Nov 15, 2019	SELL	$23.0 - $27.97 $119,600 - $145,444	-5,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $118,612 - $148,096	5,200 New	5,200 $125,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.